Celldex Announces First Patient Dosed in Phase 1 Study of CDX-0159 in Prurigo Nodularis
HAMPTON, N.J., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been...
News
Veru Announces Presentation of Preclinical Evidence Supporting the Therapeutic Benefit of Enobosarm Alone or in Synergistic Combination with a CDK4/6 Inhibitor Against Palbociclib Resistant Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing...
IntelGenx Initiates Arbitration Proceeding Against Tilray® Related to an Alleged Breach of Worldwide Cannabis-Infused VersaFilm® Agreement
SAINT LAURENT, Quebec, Dec. 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it...
SOTIO Announces Clinical Collaboration with MSD to Evaluate IL-15 Superagonist, SOT101, in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors
The Phase 2 AURELIO-04 study is expected to enroll up to 300 patients across six different indicationsThe study will be...
JDRF Canada’s First Centre of Excellence in Type 1 Diabetes Research Launches at the University of British Columbia
TORONTO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- JDRF Canada, the largest Canadian charitable funder of type 1 diabetes (T1D) research,...
Marrone Bio’s Next-Generation Product for Environmentally Sustainable Pest Control Demonstrates Substantial Yield Gains in 2021 Field Trials
Estimated peak potential revenue for MBI-306 and its variants is $100 millionDAVIS, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Field...
Corcept Therapeutics Announces Extension of Previously Announced Tender Offer
MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”) a commercial-stage company engaged in...
Talis Biomedical Announces Leadership Transition
MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health...
Ocuphire Expands Prestigious Medical Advisory Board with Six New KOLs to Support Advancement of Late-Stage Ophthalmic Assets Nyxol® and APX3330
FARMINGTON HILLS, Mich, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused...
Palisade Bio Granted New U.S. Patent Covering Protease Inhibitor LB1148 for Treating Adhesions and Postoperative Ileus
Issuance of Additional U.S. Patent No11,202,768 Further Bolsters Palisade Bio’s Patent Portfolio The Company Continues to Advance LB1148 for Key...
Monopar Advances Dosing of Camsirubicin to Higher Level Than Tested In Any Previous Clinical Trial
WILMETTE, Ill., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing...
OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug...
Dentsply Sirona and 3Shape Expand Their Strategic Partnership with Seamless Connectivity for Dentists and Dental Labs
Dentsply Sirona’s intraoral Primescan and Omnicam scanners now integrate directly with 3Shape’s lab software, delivering better workflows and patient outcomes.CHARLOTTE,...
InnerScope Hearing Technologies (OTC: INND) Receives Walmart Purchase Orders of $277,000+ for In-Store Product Sales
ROSEVILLE, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging...
Internationally Recognized Dr. Peter Centre in Vancouver Goes Live with VitalHub’s eMAR
TORONTO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is proud to announce that...
BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant
MAINZ, Germany, December 8, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will hold a digital press conference...
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB:...
The University of Colorado Anschutz Medical Campus and Orange Grove Bio to Collaborate on Development and Commercialization of Novel Therapies
Collaboration will Leverage Work of World-Class Researchers at CU Anschutz to Grow Colorado Biotech Ecosystem through Company Creation and Drug...
Ikena Appoints Michelle Zhang, Ph.D., Industry and Company Veteran, as Chief Scientific Officer
Dr. Zhang steps into the CSO role after spending more than five years at Ikena in research and development leadership...
Passage Bio Announces Pipeline Expansion and Clinical Program Update
Exercised two additional options with University of Pennsylvania’s Gene Therapy Program aligned with company’s focus on CNS diseases with high...
